An announcement from Vistin Pharma ASA ( (DE:VP4) ) is now available.
Vistin Pharma ASA has released its Annual Report for 2024, confirming that there are no significant changes in the financial statements compared to the preliminary results shared earlier in February 2025. This stability in financial reporting suggests a consistent performance by the company, which may reassure stakeholders about its operational steadiness.
More about Vistin Pharma ASA
YTD Price Performance: 0.50%
Technical Sentiment Signal: Sell
Current Market Cap: €88.42M
Find detailed analytics on VP4 stock on TipRanks’ Stock Analysis page.